Roche is on a roll: For the second time in less than a year, the company has scored FDA clearance for a pair of assays that can be used together to help spot signs of Alzheimer’s disease. The duo ...
Roche has received US Food and Drug Administration (FDA) 510(k) clearance for additional cerebrospinal fluid (CSF) assays for Alzheimer’s disease (AD), supporting timely diagnosis and treatment ...
A laboratory technician holds a blood sample in Germany. Photographer: Krisztian Bocsi/Bloomberg Senior Correspondent As the world’s population ages, health experts are bracing for higher rates of age ...
A genomic test developed at UC San Francisco to rapidly detect almost any kind of pathogen – virus, bacteria, fungus or parasite – has proved successful after a decade of use. The test has the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results